Global Myocardial Infarction (MI) Therapeutics Market 2024-2028
상품코드:1580832
리서치사:TechNavio
발행일:2024년 10월
페이지 정보:영문 149 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
심근경색(MI) 치료제 시장(2024-2028년)
심근경색(MI) 치료제 시장은 2023년부터 2028년까지 19억 2,560만 달러 규모로 성장할 것으로 예측되며, 예측 기간 동안 4.5%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 심근경색(MI) 치료제 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
이 보고서는 현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 심근경색증 발병률 증가, 새로운 항혈전제 도입 증가, 유리한 상환 제도 등에 의해 주도되고 있습니다.
시장 범위
기준 연도
2024년
종료 연도
2028년
예측 기간
2024-2028년
성장 모멘텀
가속
전년 대비(2024년)
4.2%
CAGR
4.5%
증분 금액
19억 2,560만 달러
이 보고서는 향후 몇 년간 심근경색증(MI) 치료제 시장 성장을 주도할 주요 요인 중 하나로 심근경색증 위험요인의 증가를 꼽았습니다. 또한, 심근경색증에 대한 고급 진단 방식과 환자 지원 이니셔티브의 증가로 인해 시장 수요가 크게 증가할 것으로 예상됩니다.
The myocardial infarction (Mi) therapeutics market is forecasted to grow by USD 1925.6 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the myocardial infarction (Mi) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of mi, increased adoption of novel antithrombotics, and favorable reimbursement schemes.
Market Scope
Base Year
2024
End Year
2028
Series Year
2024-2028
Growth Momentum
Accelerate
YOY 2024
4.2%
CAGR
4.5%
Incremental Value
$1925.6 mn
Technavio's myocardial infarction (Mi) therapeutics market is segmented as below:
By Product
Antithrombotics
Vasodilators
Thrombolytics
Others
By Geographical Landscape
North America
Asia
Europe
Rest of World (ROW)
This study identifies the increasing risk factors for mi as one of the prime reasons driving the myocardial infarction (Mi) therapeutics market growth during the next few years. Also, advanced diagnostic modalities for mi and rising number of patient-support initiatives will lead to sizable demand in the market.
The report on the myocardial infarction (Mi) therapeutics market covers the following areas:
Myocardial Infarction (Mi) Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading myocardial infarction (Mi) therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Athera Biotechnologies AB, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., CeleCor Therapeutics, CHIESI Farmaceutici SpA, CSL Ltd., Eli Lilly and Co., Ever Supreme Bio Technology, F. Hoffmann La Roche Ltd., Faraday Pharmaceuticals, Idorsia Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Merck and Co. Inc., Mesoblast Ltd., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the myocardial infarction (Mi) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Myocardial Infarction (MI) Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Myocardial Infarction (MI) Therapeutics Market 2018 - 2022 ($ million)
